JPRN-jRCT1091220056CompletedPhase 4
The effect of pitavastatin on the lipoprotein subfraction profile and lipid metabolism - PIT-STATION study
Tokyo Medical and Dental University0 sites100 target enrollmentStarted: January 27, 2011Last updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- >= 20age old to <= 95age old (—)
- Sex
- All
Inclusion Criteria
- •having dyslipidemia
Exclusion Criteria
- •liver dysfunction, renal dysfunction, heart failure, type 1 diabetes
Investigators
Similar Trials
Completed
Not Applicable
Proper Level of Lipid Lowering with Pitavastatin and Ezetimibe in Acute Coronary SyndromeAcute coronary syndromeJPRN-UMIN000002742Department of Cardiology, Tokyo Women's Medical University3,000
Completed
Not Applicable
Effect of Pitavastatin on high density lipoprotein cholesterol levels in hyperlipidemia.Hyperlipidemia with HDL-C <50mg/dJPRN-UMIN000013384Kanazawa Medical University Diabetology and Endocrinology50
Completed
Not Applicable
Effects of pitavastatin treatments on the plasma Lgi3 level in the patients with dyslipidemia: A randomized crossover trialKCT0003372Yonsei University Health System, Severance Hospital49
Recruiting
Not Applicable
Study of high-dose Pitavastatin on lipid and glucose metabolism disorder in Coronary Artery Disease. (Shield-CAD)Patients with stable coronary artery diseaseJPRN-UMIN000008627Minami-Osaka Hospital100
Completed
Not Applicable
comparison of pitavastatin versus EPA on lipid-lowering effect in patients with dyslipidemiadyslipidemiaJPRN-UMIN000004944niversity of Fukui Faculty of Medical Sciences, Division of cardiovascular Medicine70